drugset / Trial / NCT01718496
Morphine, Dyspnea, Exercise and COPD
Phase 3
Unknown
20 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedCrossoverDouble-blindTreatment
Summary
The investigators are studying the effect of a single dose Opioid drug (Morphine) on dyspnea and exercise tolerance in COPD patients.
Timeline
- Start
- 2014-07
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Morphine | Other / unclassified | 0.1 mg/kg | Oral |